Senior Manager, Medical Publications
Arrowhead Pharmaceuticals
Summary
The Senior Manager, Medical Publications will play a key role in developing high-quality, scientifically accurate, and strategically aligned medical publications deliverables that support Arrowhead's Medical Affairs objectives. This individual will partner closely with internal cross-functional colleagues, external authors, and vendors to translate complex scientific and clinical data into clear, compliant, and impactful materials. This role will initially support the cardiometabolic program and may evolve to support additional pipeline programs across Arrowhead.
Job description
Responsibilities
- Develop, write, edit, and coordinate high-quality medical publication deliverables, including abstracts, posters, oral presentations, manuscripts, slide decks, scientific narratives, lexicons, FAQs, and field medical resources
- Support the development and execution of integrated publication and congress plans, including identification of publication gaps, prioritization of analyses, journal/congress recommendations, and data dissemination opportunities
- Translate complex clinical, scientific, and statistical information into clear, accurate, and compelling content for internal and external audiences
- Partner with cross-functional colleagues in Medical Affairs, Clinical Development, Biostatistics, Regulatory, Legal, Compliance, Medical Information, and Program Leadership to obtain input, resolve comments, and drive documents through review and approval processes
- Collaborate with internal and external authors in accordance with GPP and ICMJE criteria and company publication policies, supporting author engagement, document development, review cycles, and congress or journal submissions
- Maintain publication records, timelines, documentation, and compliance within publication management platforms and document review systems
- Coordinate congress abstracts and journal manuscript submissions, including adherence to submission requirements, disclosures, copyright forms, and publication policies
- Support publication advisory committee activities, authorship planning, journal selection, and scientific dissemination discussions in accordance with company publication policy and GPP
- Manage timelines, review meetings, document versions, and stakeholder feedback to ensure writing deliverables are completed accurately and on time
- Provide medical writing support for congress activities, including booth or medical education resources, and post-congress summary materials
- Ensure documents are scientifically rigorous, balanced, non-promotional where appropriate, and compliant with applicable company policies, industry guidelines, journal requirements, and congress standards
- Maintain awareness of the current treatment landscape, emerging data, competitor activities, and scientific literature in assigned therapeutic areas, including cardiometabolic diseases, rare diseases, and RNA interference
- Contribute to the development and maintenance of medical writing processes, templates, style standards, and best practices across Medical Affairs
- Manage or oversee external medical writing vendors, contractors, or agencies, including scope development, timeline management, quality review, and budget tracking as needed
- Serve as a trusted medical writing partner within Medical Affairs and contribute to a collaborative, science-driven team culture
Requirements
- Advanced scientific degree required, such as PhD, PharmD, or MD
- 2+ years of relevant experience in medical publication writing, scientific communications, or medical affairs within the biotechnology, pharmaceutical, CRO, or medical communications agency setting
- Demonstrated ability to independently develop publication and medical affairs materials, including abstracts, posters, manuscripts, congress presentations, scientific slide decks, and internal scientific resources
- Demonstrated ability to critically evaluate scientific literature, clinical datasets, and reviewer feedback and translate them into effective scientific communications
- Strong understanding of publication practices, GPP, congress submission processes, authorship standards, ICMJE criteria, and relevant industry guidelines
- Experience interpreting clinical study data, statistical outputs, protocols, clinical study reports, and scientific literature to develop accurate and balanced scientific content
- Knowledge of drug development and the role of Medical Affairs in data generation, evidence dissemination, scientific exchange, and lifecycle management
- Excellent written and oral communication skills, with the ability to clearly explain complex scientific and medical concepts to varied audiences
- Demonstrated project management skills, including the ability to manage multiple priorities, timelines, stakeholders, and review cycles in a fast-paced environment
- Strong attention to detail, scientific integrity, and commitment to quality, accuracy, and compliance
- Ability to work independently while building effective relationships with cross-functional colleagues, external authors, vendors, and agency partners
Preferred
- Therapeutic area experience in cardiometabolic disease, rare disease, lipid disorders, RNA interference, or related areas is preferred
- Proficiency with Microsoft Word, PowerPoint, Excel, reference management tools, literature searching platforms, and publication management or document review systems is preferred
- Experience with Veeva and PubPro Systems a Plus
- Biostatistical training or graphics experience a Plus
- Previous experience with HEOR publications a Plus
Requirements
- Advanced scientific degree required, such as PhD, PharmD, or MD
- 2+ years of relevant experience in medical publication writing, scientific communications, or medical affairs within the biotechnology, pharmaceutical, CRO, or medical communications agency setting
- Demonstrated ability to independently develop publication and medical affairs materials, including abstracts, posters, manuscripts, congress presentations, scientific slide decks, and internal scientific resources
- Demonstrated ability to critically evaluate scientific literature, clinical datasets, and reviewer feedback and translate them into effective scientific communications
- Strong understanding of publication practices, GPP, congress submission processes, authorship standards, ICMJE criteria, and relevant industry guidelines
- Experience interpreting clinical study data, statistical outputs, protocols, clinical study reports, and scientific literature to develop accurate and balanced scientific content
- Knowledge of drug development and the role of Medical Affairs in data generation, evidence dissemination, scientific exchange, and lifecycle management
- Excellent written and oral communication skills, with the ability to clearly explain complex scientific and medical concepts to varied audiences
- Demonstrated project management skills, including the ability to manage multiple priorities, timelines, stakeholders, and review cycles in a fast-paced environment
- Strong attention to detail, scientific integrity, and commitment to quality, accuracy, and compliance
- Ability to work independently while building effective relationships with cross-functional colleagues, external authors, vendors, and agency partners
Benefits
- Competitive salaries
- Excellent benefit package
Company overview
Arrowhead Pharmaceuticals, Inc. is a publicly traded biotechnology company headquartered in Pasadena, California, specializing in the development of gene silencing therapeutics through RNA interference (RNAi) technology. Founded in 2004 and listed on Nasdaq under the ticker ARWR, the company focuses on treating intractable diseases by silencing disease-causing genes. Arrowhead's innovative TRiM (Targeted RNAi Molecule) platform enables precise targeting of specific messenger RNAs to reduce production of proteins associated with various conditions. The company's pipeline includes treatments for hepatitis B, liver diseases associated with alpha 1-antitrypsin deficiency, cardiovascular diseases, hypertriglyceridemia, and other metabolic disorders. With approximately 609 employees, Arrowhead has established significant partnerships with major pharmaceutical companies including Janssen, Amgen, and Takeda, demonstrating the commercial potential of its RNAi platform. The company recently achieved FDA approval for its therapy targeting Familial Chylomicronemia Syndrome (FCS), marking a significant milestone in its mission to revolutionize treatment approaches for challenging diseases.